News | December 07, 2025
Paradigm Health to acquire Flatiron’s clinical research business
It's an acquisition that aims at forming one of the US's largest oncology trial networks
It's an acquisition that aims at forming one of the US's largest oncology trial networks
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
Subscribe To Our Newsletter & Stay Updated
